Semaglutide enhanced cellular regeneration in skin and retinal cells in vitro, revealing direct tissue repair properties beyond its metabolic effects.
Key findingSemaglutide enhanced cellular regeneration in skin and retinal cells in vitro, revealing direct tiss
What the researchers found
Semaglutide enhanced cellular regeneration in skin and retinal cells in vitro, revealing direct tissue repair properties beyond its metabolic effects.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
Specific numerical results not available from abstract; study measured oxidative stress markers and wound closure rates in cell cultures.
How the study worked
In publication.
Who was studied
Human dermal fibroblasts and retinal cells (in vitro)
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro.
Pharmaceutics, 17(9)
Citation
Anastasiou, Ioanna A; Tentolouris, Anastasios; Sarantis, Panagiotis; Katsaouni, Athanasia; Rebelos, Eleni; Mourouzis, Iordanis; Pantos, Constantinos; Tentolouris, Nikolaos. (2025). Semaglutide Enhances Cellular Regeneration in Skin and Retinal Cells In Vitro.. Pharmaceutics, 17(9). https://doi.org/10.3390/pharmaceutics17091115